English
GlaxoSmithKline Pharmaceuticals Q1 Results
- BSE: 500660
- NSE: GLAXO
- ISIN: INE159A01016
- Sector: Biotechnology & Drugs
BSE
2,614.95
23.55 (0.91%)
23.55 (0.91%)Volume2.26 K
Updated: Thu 11 Dec, 2025 | 15:29:54
NSE
2,622.1028.80 (1.11%)
28.80 (1.11%)Volume74.84 K
Updated: Thu 11 Dec, 2025 | 15:54:43
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - GlaxoSmithKline Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 569.49 | 655.90 | -13.17% | 600.52 | -5.17% |
| Depreciation/ Amortization | 15.52 | 14.72 | 5.42% | 16.41 | -5.42% |
| Operating Income | 235.68 | 318.47 | -26.00% | 214.13 | 10.06% |
| Net Income | 205.01 | 262.87 | -22.01% | 182.33 | 12.44% |
| Other Operating Expenses Total | 113.69 | 136.27 | -16.57% | 137.56 | -17.35% |
| Net Income Before Taxes | 278.98 | 358.57 | -22.20% | 249.40 | 11.86% |
| Total Revenue | 805.17 | 974.37 | -17.37% | 814.65 | -1.16% |
| Selling/ General/ Admin Expenses Total | 152.57 | 152.97 | -0.26% | 151.28 | 0.85% |
| Diluted Normalized EPS | 12.10 | 15.51 | -22.01% | 10.76 | 12.45% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.